1H NMR (CDCl3) δ 4.00 (3H, s, OCH3), 4.54 (2H, s, CH2),
4.57 (2H, s, CH2), 6.97 (1H, d, J 8.6 Hz, ArH), 7.47 (1H, t, J 6.8
Hz, ArH), 7.60–7.70 (2H, m, 2 × ArH), 7.79 (1H, s, ArH), 7.81
(1H, dd, J1 8.6 Hz, J2 2.0 Hz, ArH), 7.87 (1H, d, J 2.0 Hz, ArH);
13C NMR (normal/DEPT-135) (CDCl3) δC 27.81 (Ϫve, CH2),
32.48 (Ϫve, CH2), 55.93 (ϩve, OCH3), 110.34 (ϩve, ArCH),
126.30 (ab, ArC), 128.69 (ϩve, ArCH), 129.49 (ϩve, ArCH),
129.67 (ab, ArC), 130.07 (ϩve, ArCH), 133.41 (ϩve, ArCH),
133.02 (ϩve, ArCH), 133.06 (ϩve, ArCH), 138.05 (ab, ArC),
J 7.8 Hz, ArH), 7.36 (2H, d, J 7.8 Hz, ArH), 7.50 (2H, dd, J1 7.8
Hz, J2 1.8 Hz, ArH), 7.58 (2H, s, ArH), 7.66 (2H, s, ArH); 13
C
NMR (normal/DEPT-135) (CDCl3) δC 40.71 (Ϫve, NCH2),
44.60 (Ϫve, NCH2), 55.50 (ϩve, OCH3), 110.00 (ϩve, ArCH),
112.04 (ϩve, ArCH), 121.32 (ϩve, ArCH), 121.77 (ϩve,
ArCH), 123.70 (ϩve, ArCH), 128.26 (ϩve, ArCH), 128.67 (ab,
ArC), 128.78 (ϩve, ArCH), 129.03 (ab, ArC), 129.21 (ab, ArC),
129.53 (ϩve, ArCH), 130.74 (ϩve, ArCH), 131.09 (ϩve,
ArCH), 132.58 (ϩve, ArCH), 135.91 (ab, ArC), 137.18 (ab,
138.40 (ab, ArC), 160.96 (ab, ArC), 194.13 (ab, C᎐O);
ArC), 154.05 (ab, C᎐O), 155.54 (ab, C᎐O), 161.10 (ab, ArC),
᎐
᎐ ᎐
νmax(KBr)/cmϪ1 1660 (Calc. for C16H14Br2O2: C, 48.24; H, 3.52.
192.91 (ab, C᎐O); νmax(KBr)/cmϪ1 1669, 1718.
᎐
Found: C, 48.8; H, 4.0%).
Compound 7. (60%), mp 230 ЊC (from MeOH ϩ CHCl3);
General procedure for the synthesis of 5–9
1
m/z 348 (Mϩ); H NMR (CDCl3) δ 3.97 (3H, s, OCH3), 4.59,
A suspension of dibromide 4 (3.98 g, 0.01 mol) and 1,3-
dihydrobenzimidazol-2-one (1.34 g, 0.01 mol) in acetonitrile
(700 ml) containing K2CO3 (12 g) and tetrabutylammonium
hydrogen sulfate (TBAؒHSO4) (50 mg) was heated to reflux
and the progress of reaction was monitored by TLC. After the
completion of reaction, suspended solid was filtered off and
the filtrate was concentrated under vacuum and the residue
was subjected to column chromatography to afford pure
product 5. Similarly, the reactions of dibromide 4 with 1,3-
dihydro-5,6-dinitrobenzimidazol-2-one,10 uracil, 6-methyluracil
and quinazoline-2,4(1H,3H)-dione gave the respective calix-
arenes 6–9.
5.48 (2H, two doublets, J 16.0 Hz, N3-CH2), 5.16, 5.49 (2H,
two doublets, J 14.2 Hz, N1-CH2), 5.66 (1H, d, J 7.8 Hz,
U5Ј-H), 7.00 (1H, d, J 8.6 Hz, C11-H), 7.04 (1H, br s, C14-
H), 7.11 (1H, d, J 7.8 Hz, U6Ј-H), 7.37 (1H, br s, C7-H),
7.44 (1H, t, J 7.6 Hz, C4-H), 7.59 (1H, d, J 7.6 Hz, C3-H),
7.80 (1H, d, J 7.6 Hz, C5-H), 7.96 (1H, dd, J1 8.4 Hz, J2 2.0
Hz, C10-H); 13C NMR (normal/DEPT-135) (CDCl3) δ 44.37
(Ϫve, CH2), 49.58 (Ϫve, CH2), 55.87 (ϩve, OCH3), 102.56
(ϩve, U5-CH), 110.53 (ϩve, ArCH), 122.87 (ab, ArC), 127.75
(ϩve, ArCH), 128.65 (ab, ArCH), 130.47 (ab, ArC), 130.79
(ϩve, ArCH), 131.87 (ϩve, ArCH), 132.54 (ϩve, ArCH),
133.99 (ϩve, ArCH), 136.74 (ab, ArC), 137.76 (ab, ArC),
142.94 (ϩve, U6-CH), 152.60 (ab, ArC), 159.43 (ab, C᎐O),
᎐
162.29 (ab, C᎐O), 194.14 (ab, C᎐O); νmax(KBr)/cmϪ1 1660,
1725 (Calc. for C20H16N2O4: C, 68.69; H, 4.60; N, 8.05.
Found: C, 69.0; H, 4.76; N, 7.5%).
Compound 5. (40%), mp 201–203 ЊC (from MeOH ϩ CHCl3);
᎐
᎐
1
m/z 370 (Mϩ); H NMR (CDCl3) δ 4.01 (3H, s, OCH3), 4.82,
5.53 (2H, two doublets, J 16.6 Hz, NCH2), 4.98, 5.34 (2H, two
doublets, J 16.6 Hz, NCH2), 6.62 (1H, s, C14-H), 6.94 (1H, d,
J 8.6 Hz, C11-H), 6.96 (4H, br s, benzim, ArH), 7.17 (1H, s,
C7-H), 7.37 (1H, t, J 6.6 Hz, C4-H), 7.53 (1H, d, J 7.6 Hz,
C3-H), 7.68 (1H, d, J 7.6 Hz, C5-H), 7.87 (1H, dd, J1 8.6 Hz,
J2 2.2 Hz, C10-H); 13C NMR (normal/DEPT-135) (CDCl3)
δC 40.51 (Ϫve, CH2), 46.27 (Ϫve, CH2), 55.76 (ϩve, OCH3),
108.94 (ϩve, ArCH), 109.46 (ϩve, ArCH), 110.22 (ϩve,
ArCH), 121.90 (ϩve, ArCH), 122.09 (ϩve, ArCH), 123.78
(ab, ArC), 127.79 (ϩve, ArCH), 128.16 (ϩve, ArCH), 129.51
(ab, ArC), 130.18 (ϩve, ArCH), 130.96 (ab, ArC), 131.16
(ϩve, ArCH), 133.45 (ϩve, ArCH), 134.82 (ϩve, ArCH),
136.70 (ab, ArC), 137.64 (ab, ArC), 158.11 (ab, C), 160.45
Compound 8. (65%), mp 242 ЊC (from MeOH ϩ CHCl3);
m/z 362 (Mϩ); 1H NMR (CDCl3) δ 2.21 (3H, s, U6Ј-CH3), 3.98
(3H, s, OCH3), 4.89, 5.40 (2H, two doublets, J 16.6 Hz, N3-
CH2), 5.20, 5.46 (2H, two doublets, J 14.0 Hz, N1-CH2), 5.54
(1H, s, U5Ј-H), 7.01 (1H, d, J 8.8 Hz, C11-H), 7.03 (1H, s,
C14-H), 7.44 (1H, t, J 7.6 Hz, C4-H), 7.54 (1H, s, C7-H),
7.60 (1H, d, J 7.6 Hz, C3-H), 7.80 (1H, d, J 7.6 Hz, C5-H),
8.00 (1H, dd, J1 8.6 Hz, J2 1.6 Hz, C10-H); 13C NMR
(CDCl3) δC 19.87 (ϩve, CH3), 44.12 (Ϫve, NCH2), 44.48
(Ϫve, NCH2), 55.71 (ϩve, OCH3), 102.23 (ϩve, U5-CH),
110.47 (ϩve, ArCH), 122.52 (ab, ArC), 127.72 (ϩve, ArCH),
128.51 (ϩve, ArCH), 130.05 (ab, ArC), 130.53 (ϩve, ArCH),
131.94 (ϩve, ArCH), 132.81 (ϩve, ArCH), 133.88 (ϩve,
ArCH), 136.90 (ab, ArC), 137.49 (ab, ArC), 151.53 (ab, ArC),
(ab, C), 193.55 (ab, C᎐O); νmax(KBr)/cmϪ1 1656, 1678 (Calc.
᎐
for C23H18N2O3: C, 74.59; H, 4.86; N, 7.56. Found: C, 74.1;
H, 4.2; N, 8.0%).
153.31 (ab, ArC), 159.44 (ab, C᎐O), 161.239 (ab, C᎐O),
᎐
᎐
Compound 6. (28%), mp 296–298 ЊC (from MeOH ϩ CHCl3);
193.80 (ab, C᎐O); νmax(KBr)/cmϪ1 1658, 1716 (Calc. for
᎐
1
m/z 460 (Mϩ); H NMR (CDCl3) δ 4.13 (3H, s, OCH3), 5.15,
C21H18N2O4: C, 69.61; H, 4.97; N, 7.73. Found: C, 69.4; H,
4.6; N, 7.5%).
5.62 (2H, two doublets, J 16.6 Hz, NCH2), 5.24, 5.49 (2H, two
doublets, J 16.6 Hz, NCH2), 6.66 (1H, br s, C7-H), 6.79 (1H, br
s, C14-H), 7.09 (1H, d, J 8.6 Hz, C11-H), 7.57 (1H, t, J 7.6 Hz,
C4-H), 7.66 (1H, d, J 7.6 Hz, benzim, ArH), 7.70 (1H, d, J 7.6
Hz, C3-H), 7.72 (1H, s, benzim. ArH), 7.86 (1H, d, J 7.6 Hz,
C5-H), 7.98 (1H, dd, J1 8.6 Hz, J2 2.0 Hz, C10-H); 13C NMR
(normal/DEPT-135) (CDCl3) δC 41.52 (Ϫve, CH2), 47.54 (Ϫve,
CH2), 56.21 (ϩve, OCH3), 106.33 (ϩve, ArCH), 107.70 (ϩve,
ArCH), 111.18 (ϩve, ArCH), 122.61 (ab, ArC), 129.00 (ϩve,
ArCH), 129.43 (ϩve, ArCH), 132.14 (ϩve, ArCH), 132.33
(ϩve, ArCH), 132.61 (ab, ArC), 132.79 (ϩve, ArCH), 134.69
(ab, ArC), 135.63 (ϩve, ArCH), 137.22 (ab, ArC), 138.92
(ab, ArC), 139.11 (ab, ArC), 158.33 (ab, C), 161.15 (ab, C),
Compound 9. (42%), mp 222 ЊC (from MeOH ϩ CHCl3);
1
m/z 398 (Mϩ); H NMR (CDCl3) δ 4.01 (3H, s, OCH3), 5.25,
5.80 (2H, two doublets, J 14.6 Hz, NCH2), 5.30, 5.65
(2H, two doublets, J 16.2 Hz, NCH2), 6.96 (1H, d, J 8.6 Hz,
C11-H), 7.22 (1H, t, J 7.4 Hz, quinaz. 7Ј-H), 7.36 (2H, br s, C7-,
C14-H), 7.46 (1H, t, J 7.4 Hz, C4-H), 7.48 (1H, d, J 7.8 Hz,
quinaz. 8Ј-H), 7.58–7.66 (2H, m, C3- and quinaz. 6Ј-H), 7.78
(1H, d, J 7.6 Hz, C5-H), 7.93 (1H, dd, J1 8.4 Hz, J2 2.2 Hz,
C10-H), 8.18 (1H, dd, J1 7.8 Hz, J2 1.2 Hz, quinaz. 5Ј-H); 13C
NMR (normal/DEPT-135) (CDCl3) δC 42.88 (Ϫve, NCH2),
45.96 (Ϫve, NCH2), 55.76 (ϩve, OCH3), 111.07 (ϩve, ArCH),
114.43 (ϩve, ArCH), 114.92 (ab, ArC), 124.92 (ϩve, ArCH),
128.64 (ϩve, ArCH), 128.80 (ab, ArC), 129.24 (ϩve, ArCH),
129.45 (ϩve, ArCH), 131.98 (ϩve, ArCH), 133.24 (ϩve,
ArCH), 135.46 (ab, ArC), 136.20 (ϩve, ArCH), 136.61
(ϩve, ArCH), 136.76 (ϩve, ArCH), 139.22 (ab, ArC), 152.81
196.77 (ab, C᎐O); νmax(KBr)/cmϪ1 1661, 1730 (Calc. for
᎐
C23H16N4O7: C, 60.00; H, 3.48; N, 12.17. Found: C, 60.1; H, 3.2;
N, 11.8%).
Compound 10. (< 2%), mp 279–283 ЊC (from CHCl3); m/z 740
1
(Mϩ); H NMR (CDCl3) δ 4.67 (6H, s, 2 × OCH3), 5.08 (4H,
s, NCH2), 5.16 (4H, s, NCH2), 6.53 (4H, d, J 8.0 Hz, ArH),
6.79–6.93 (4H, m, ArH), 6.97–7.24 (4H, m, ArH), 7.26 (2H, d,
(ab, ArC), 161.63 (ab, C᎐O), 163.40 (ab, C᎐O), 199.15 (ab,
᎐ ᎐
C᎐O); νmax(KBr)/cmϪ1 1662 (C᎐O), 1716 (C᎐O) (Calc. for
᎐
᎐
᎐
2300
J. Chem. Soc., Perkin Trans. 1, 2000, 2295–2301